Search Results
21 results found-
OFR 1 Chair and CEO message 2 8 Environment 46 2 Our Company 8 9 Social 53 3 CSL's Performance and Strategy 20 OFR 10 CSL's Governance 60 4 CSL's Material Risks 26 11 Share Information 70 5 CSL's Future Prospects 28 12 Key Performance Data Summary 73 6 Powered by Innovation 32 13 Medical Glossary 74 7 CSL's People 40 OFR 14 Financial Performance 75
https://www.csl.com/-/media/shared/documents/annual-report/csl-annual-report-2023.pdf -
Equity and Reserves (a) Contributed Equity 2024 2023 US$m US$m Ordinary shares issued and fully paid 5,062 5,022 Share buy-back reserve (4,505) (4,505) Total contributed equity 557 517
https://www.csl.com/-/media/shared/documents/annual-report/csl-annual-report-2024.pdf -
Limit the daily dose of simvastatin (20 mg) and rosuvastatin (5 mg).
https://newsroom.csl.com/2024-03-28-Vafseo-R-approved-by-the-U-S-FDA-for-the-treatment-of-anemia-due-to-chronic-kidney-disease-in-dialysis-dependent-adult-patients -
Biotech leader CSL has manufacturing centers, sales offices, and locations to serve patients and public health around the globe.
https://www.csl.com/we-are-csl/worldwide-locations -
This was added as a gateway condition of the LTI target to ensure the ROIC is delivering an appropriate return each financial year as well as over the seven year rolling 0% 20% 40% 60% 80% 100% average period and aligns with shareholder outcomes.
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2020-full.pdf -
For our executive KMP in 2019, the Board has approved an average 4% increase in Fixed Reward, no increase in STI and an average 30% increase 0% 20% 40% 60% 80% 100% in LTI targets to recognise that our executive KMP LTI component is significantly below global market comparators.
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2018-full.pdf -
68 CSL Limited Annual Report 2017 200 60% 35% 35% 35% 160 43% 43% 43% 43% 43% 60% 120 43% 43% 43% 43% 43% 80 35% 35% 35% 40 120% 70% 85% 70% 85% 85% 70% 85% 85% 0 L Reed L Reed G Boss G Boss G Naylor G Naylor R Repella R Repella D Lamont D Lamont P Perreault P Perreault V Romberg V Romberg K Etchberger K Etchberger A Cuthbertson A Cuthbertson
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2017-full.pdf -
VFMCRPE 2023 Federación Nacional ALCER ESPAÑA Patrocinio 36ª ED.
https://www.csl.com/-/media/shared/documents/vifor-disclosures/tov/20240621transparencia-organizacin-de-pacientes-2023final-v2-1.pdf -
MIGUEL SERVET- C. DE IRUNLARREA, 3 - PAMPLONA/IRUÑA Spain G31187420 8.000,00 8.000,00 NAVARRABIOM 31008-PAM ED
https://www.csl.com/-/media/shared/documents/vifor-disclosures/tov/spain-efpia_sp08july2024-updated-final.pdf -
Ready for a challenge? CSL's Summer Internship Program offers roles in Engineering, Manufacturing, Research & Development, Business Operations, and more
https://www.csl.com/careers/early-careers-at-csl/internships/internships-in-the-us